PR Newswire PharmaOriginal article
BD Reports Third Quarter Fiscal 2026 Financial Results
EarningsPositive
AI Analysis
Summary
BD reported third quarter fiscal 2026 earnings with revenue of $5.0 billion, up 4.4% on a currency-neutral basis, and adjusted diluted EPS of $3.23. Year-to-date cash from continuing operations increased 33.3% to $2.1 billion with free cash flow up 44.6% to $1.7 billion.
Financial Highlights
Revenue
$5.0 billion, +5.4% as reported, +4.4% FXN
EPS
GAAP $1.64, Adjusted $3.23
Importance:3/10
Sentiment:
0.30
EarningsQ3 FY2026Revenue GrowthCash Flow
Related Companies
Read the original article
Published by PR Newswire Pharma on August 6, 2026 10:30 AM
